Key result
Review outlines the clinical presentation, histology, biomarkers, and management of liver injury secondary to HF.
Why the study?
Current literature lacks comprehensive descriptions of the effects of heart failure on hepatic function.
This review highlights the clinical, histological, and biochemical features of cardiohepatic interactions in heart failure, emphasizing the prognostic value of liver function tests and implications for drug metabolism and management.
Highlights the prognostic utility of routine liver function testing in heart failure; leaves open the need for prospective trials.
Heart failure (HF) is a major public health problem leading to frequent hospitalizations, impaired quality of life, and shortened life expectancy. Heart failure leads to a chronic inability to meet metabolic requirements of end organs or skeletal muscle. Current literature lacks comprehensive descriptions of HF effects on hepatic function. In this review paper, we summarize the literature that is available in hopes of highlighting the key differences in clinical presentation, histological findings, and biochemical profiles of patients who present with both acute and chronic liver injury secondary to HF. We further discuss the use of liver function tests as prognostic markers in patients with HF, as well as the implications of liver injury on drug metabolism in this patient population. Finally, we provide recommendations regarding the management of both types of liver injury in HF patients.
No takes yet. Share an insight, caveat, or question.
Samsky et al. (2013) conducted a review in Heart failure with secondary liver injury. This review summarizes the clinical presentation, histological findings, and biochemical profiles of acute and chronic liver injury secondary to heart failure, alongside management recommendations.
Synapse has enriched 5 related papers. Consider them for comparative context: